A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

I had $3,000 when the stock market crashed in 2020. I immediately invested that in stocks, letting myself become homeless ...

Secretary Robert F. Kennedy Jr. to disclose details about several private dinners he attended with Donald Trump and ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

Analysts acknowledged the long-term manufacturing deal could dull Viking’s takeout prospects but hailed it as a smart move to ensure supply.

Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results ...

She's proud to be John Hiatt's daughter, but after 13 years of releasing her own music Lilly Hiatt is confident she's forged her own path in the music biz -- including with her new album, "Forever." ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.